» Articles » PMID: 17302978

Evaluating Antibiotics for Use in Medicine Using a Poloxamer Biofilm Model

Overview
Publisher Biomed Central
Date 2007 Feb 17
PMID 17302978
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Wound infections, due to biofilms, are a constant problem because of their recalcitrant nature towards antibiotics. Appropriate antibiotic selection for the treatment of these biofilm infections is important. The traditional in vitro disc diffusion method for antibiotic selection uses bacterial cultures grown on agar plates. However, the form of bacterial growth on agar is not representative of how bacteria grow in wounds and other tissue sites as here bacteria grow naturally in a biofilm. The aim of this research was to test a more appropriate method for testing antimicrobial efficacy on biofilms and compare with the standard methods used for antibiotic sensitivity testing.

Methods: Outer Membrane Protein analysis was performed on E.coli, Staphylococcus aureus, Pseudomonas aeruginosa, Proteus mirabilis and Acinetobacter juni when grown on Mueller Hinton agar ('quasi-biofilm state') and 30% Poloxamer hydrogel ('true- biofilm state). Susceptibility to antibiotics on 28 clinical isolates was determined using the modified Kirby Bauer disc diffusion method, on agar and 30% Poloxamer.

Results: Similar outer membrane proteins [OMPs] were identified in bacteria grown in a biofilm state and on a 30% poloxamer hydrogel, which were very different to the OMPs identified in bacteria grown on Mueller-Hinton agar and broth. There was a significant difference between the means of the clearance zones around the antibiotic discs on standard agar and poloxamer gels [P < 0.05]. The zones of clearance were generally smaller for poloxamer-grown bacteria than those grown on standard agar. Diffusion distances of various antibiotics through agar and 30% poloxamer showed no significant difference [P > 0.05].

Conclusion: The findings of this experiment suggest that poloxamer gel could be used as an appropriate medium on which to conduct biofilm antibiotic susceptibility tests as it enables bacteria to be grown in a state representative of the infected surface from which the culture was taken.

Citing Articles

Alternative Antibiotics in Dentistry: Antimicrobial Peptides.

Griffith A, Mateen A, Markowitz K, Singer S, Cugini C, Shimizu E Pharmaceutics. 2022; 14(8).

PMID: 36015305 PMC: 9412702. DOI: 10.3390/pharmaceutics14081679.


In Vitro Antimicrobial Susceptibility Testing of Biofilm-Growing Bacteria: Current and Emerging Methods.

Di Bonaventura G, Pompilio A Adv Exp Med Biol. 2021; 1369:33-51.

PMID: 33963526 DOI: 10.1007/5584_2021_641.


Gel-Entrapped Staphylococcus aureus Bacteria as Models of Biofilm Infection Exhibit Growth in Dense Aggregates, Oxygen Limitation, Antibiotic Tolerance, and Heterogeneous Gene Expression.

Pabst B, Pitts B, Lauchnor E, Stewart P Antimicrob Agents Chemother. 2016; 60(10):6294-301.

PMID: 27503656 PMC: 5038234. DOI: 10.1128/AAC.01336-16.


A Novel Qualitative and Quantitative Biofilm Assay Based on 3D Soft Tissue.

Hakonen B, Lonnberg L, Larko E, Blom K Int J Biomater. 2014; 2014:768136.

PMID: 24696687 PMC: 3948644. DOI: 10.1155/2014/768136.


Innovative strategies to overcome biofilm resistance.

Taraszkiewicz A, Fila G, Grinholc M, Nakonieczna J Biomed Res Int. 2013; 2013:150653.

PMID: 23509680 PMC: 3591221. DOI: 10.1155/2013/150653.


References
1.
Gilbert P, Jones M, Allison D, Heys S, Maira T, Wood P . The use of poloxamer hydrogels for the assessment of biofilm susceptibility towards biocide treatments. J Appl Microbiol. 1999; 85(6):985-90. DOI: 10.1111/j.1365-2672.1998.tb05262.x. View

2.
Costerton J . Overview of microbial biofilms. J Ind Microbiol. 1995; 15(3):137-40. DOI: 10.1007/BF01569816. View

3.
Lloyd D . Chemotherapy: yesterday, today and tomorrow. Vet Dermatol. 2021; 9(2):73-74. DOI: 10.1046/j.1365-3164.1998.00106.x. View

4.
Rickard A, Gilbert P, Handley P . Influence of growth environment on coaggregation between freshwater biofilm bacteria. J Appl Microbiol. 2004; 96(6):1367-73. DOI: 10.1111/j.1365-2672.2004.02297.x. View

5.
Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G . The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest. 2003; 112(10):1466-77. PMC: 259139. DOI: 10.1172/JCI20365. View